| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 08/05/2009 | CN101497615A Substituted purine, preparation and use in medicine |
| 08/05/2009 | CN101496890A Chinese medicinal composition for treating neurasthenia and preparation method thereof |
| 08/05/2009 | CN101496889A Chinese medicinal composition for tranquilizing mind, quieting spirit, soothing liver and relieving depression, and preparation method thereof |
| 08/05/2009 | CN101496871A Chinese medicinal composition with functions for tonifying blood and improving sleep as well as preparation method thereof |
| 08/05/2009 | CN101496865A Chinese medicament preparation for treating depression and anxiety as well as preparation method thereof |
| 08/05/2009 | CN101496863A Chinese medicinal composition for treating anypnia and preparation method thereof |
| 08/05/2009 | CN101496854A Chinese medicine sobering-up composition and Chinese medicine sobering-up beverage |
| 08/05/2009 | CN101496835A Antipyretic medicament for treating common cold of children and preparation method thereof |
| 08/05/2009 | CN101496833A Liquid external preparation for preparing total alkaloids in nux vomica |
| 08/05/2009 | CN101496830A Use of selective inhibitor of catecholamine transporter and medicinal preparation thereof |
| 08/05/2009 | CN101496803A Application of compound taurine and ansiolin in preparing medicament for treating brain injury disease |
| 08/05/2009 | CN101496802A Use of arylpiperazine derivatives in preparing medicament for treating ache |
| 08/05/2009 | CN101496801A Dexmedetomidine and use of pharmaceutical salt thereof |
| 08/05/2009 | CN101496797A Salvianolic acid A phospholipid complexes and preparation method thereof |
| 08/05/2009 | CN101496635A Honeysuckle and chrysanthemum composite sucking article |
| 08/05/2009 | CN100522976C Novel azacyclic ethynyl derivatives |
| 08/05/2009 | CN100522972C Fused heterocyclic isoxazoline derivatives and their use as anti-depressants |
| 08/05/2009 | CN100522967C Phosphorus-containing compounds & uses thereof |
| 08/05/2009 | CN100522964C Pyrazolo and imidazo-pyrimidine derivatives |
| 08/05/2009 | CN100522963C Pyrroloimidazole derivatives, their preparation, pharmaceutical composition containing them, and their use as nootropic agents |
| 08/05/2009 | CN100522959C Preparation and application of a category of 6 - aryl - 3 - cycroamido methyl pyrone derviation |
| 08/05/2009 | CN100522954C Kappa-opioid receptor agonist composed of 2-phenylbenzothiazoline derivative |
| 08/05/2009 | CN100522946C Stabilization of hypoxia inducible factor (HIF) alpha |
| 08/05/2009 | CN100522945C Substituted 2-thio-3,5-dicyano-4-phenyl-6-aminopyridines and use thereof |
| 08/05/2009 | CN100522944C Carboxylic acid derivative and thereof |
| 08/05/2009 | CN100522240C Medicinal composition for treating and improving brain function, its preparation method and application |
| 08/05/2009 | CN100522228C Chinese traditional medicine preparation for treating mental disease |
| 08/05/2009 | CN100522212C Traditional Chinese medicine composition for treating depression and its preparing method |
| 08/05/2009 | CN100522210C Medicinal composition for treating aphronesia and preparing process thereof |
| 08/05/2009 | CN100522194C Traditional Chinese medicine for treating oral paralysis and preparing process thereof |
| 08/05/2009 | CN100522186C Sustained release capsules of ginkgo leaf and preparation method |
| 08/05/2009 | CN100522172C Non-sedating barbiturate compounds as neuroprotective agents |
| 08/05/2009 | CN100522171C 1-benzoyl-piperazine derivatives as glycine uptake inhibitors for the treatment of psychoses |
| 08/05/2009 | CN100522168C Sustained releasing capsule of rotundine and its preparation method |
| 08/05/2009 | CN100522166C (1-4-piperidinyl) benzimidazole derivatives useful as histamine H3 antagonists |
| 08/05/2009 | CN100522164C Method of treating of demyelinating diseases or conditions |
| 08/05/2009 | CN100522163C Small volume vincamine injection and its preparation process |
| 08/05/2009 | CN100522157C Treatment of diseases involving defective gap junctional communication |
| 08/05/2009 | CN100522155C Use of retigabin for treating neuropathic pain |
| 08/05/2009 | CN100522152C Cinnamic acid dimers, their preparation and the use thereof for treating neurodegenerative disease |
| 08/05/2009 | CN100522149C Novel application of peptide class of compound for treating allodynia or other different types of chronic or phantom pain |
| 08/05/2009 | CN100522148C Inclusion cyclodextrin/vanillin ex polar bear medicinal composition and its preparing method |
| 08/04/2009 | US7569609 Treating Alzheimer's disease with 2-propylpentanoic acid (valproic acid) or salts thereof; improving the GABAA receptor responses |
| 08/04/2009 | US7569608 Pentanoic acid derivatives |
| 08/04/2009 | US7569592 Heteroaryl substituted pyrazole modulators of metabotropic glutamate receptor-5 |
| 08/04/2009 | US7569585 Drugs; analgesics; anesthetics; antiarrhythmia agents; antiinflammatory agents ; incontinence; gastrointestinal disorders; neurodegenerative disease |
| 08/04/2009 | US7569576 Cyclic 1-(acyloxy)-alkyl prodrugs of GABA analogs, compositions and uses thereof |
| 08/04/2009 | US7569571 Such as N-cyclopropyl-4-methyl-3-(4-phenyl-pyrazolo[3,4-d]pyrimidin-1-yl)-benzamide; for inhibiting p38 kinase mediated diseases and disorders such as inflammatory diseases |
| 08/04/2009 | US7569570 N-{4-[1-(2,6-difluorobenzyl)-3-(4-fluorophenyl)-5-({methy[2-(2-oxo-1-piperidinyl)ethyl]amino}methyl)-2,4-dioxo-1,2,3,4-tetrahydrothieno[2,3-d]pyrimidin-6-yl]phenyl}-N'-ethylurea; antagonistic action for gonadotropin-releasing hormone |
| 08/04/2009 | US7569569 Pyrrolo[2,3-d]pyrimidine compounds |
| 08/04/2009 | US7569567 3-Heteroaryl-3,5-dihydro-4-oxo-4H-pyridazino[4,5-B]indole-1-carboxamide derivatives, their preparation and therapeutic use |
| 08/04/2009 | US7569227 Monomeric protein of the TGF-β family |
| 08/04/2009 | CA2496476C Therapeutic use |
| 08/04/2009 | CA2457996C Medicinal preparation containing phenylethanoid glycosides extracted from herbaceous plant, cistanche tubulosa (schenk.) wight, process of making the same, and uses of the same |
| 08/04/2009 | CA2436511C Use of flumazenil to produce a medicament for the treatment of cocaine dependency |
| 08/04/2009 | CA2417837C Compositions for ameliorating attention-deficient/hyperactivity disorder |
| 08/04/2009 | CA2406057C Methods and compositions for modulating alpha adrenergic receptor activity |
| 08/04/2009 | CA2365281C Human antibodies that bind human il-12 and methods for producing |
| 08/04/2009 | CA2334727C Tetrahydroquinoline derivatives as glycine antagonists |
| 08/04/2009 | CA2323090C In vitro formation of congophilic maltese-cross amyloid plaques to identify anti-plaque therapeutics for the treatment of alzheimer's and prion diseases |
| 08/04/2009 | CA2322745C Method of treating neuroma pain |
| 08/04/2009 | CA2275425C Aminoindan derivatives |
| 08/04/2009 | CA2207850C Use of mono and bicarboxylic acid amides for the manufacture of a medicament active at the peripheral cannabinoid receptor |
| 07/30/2009 | WO2009094577A2 Mesophasic forms of calcium-salts of (3s)-aminomethyl-b-methyl-hexanoic acids and methods of use |
| 07/30/2009 | WO2009094563A2 Crystalline form of calcium-salts of (3s)-aminomethyl-b-methyl-hexanoic acids and methods of use |
| 07/30/2009 | WO2009094340A2 Omentum and use thereof |
| 07/30/2009 | WO2009094260A1 Kappa selective opioid receptor antagonist |
| 07/30/2009 | WO2009094209A1 Oligomer-diarylpiperazine conjugates |
| 07/30/2009 | WO2009094028A1 Aldh-2 inhibitors in the treatment of addiction |
| 07/30/2009 | WO2009093761A1 Medicinal composition for inhibiting amyloid-β protein deposition |
| 07/30/2009 | WO2009093747A1 Tricyclic compounds having corticotropin-releasing factor antagonistic activity and pharmaceutical compositions containing them |
| 07/30/2009 | WO2009093671A1 Antidepressant/antianxiety agent |
| 07/30/2009 | WO2009093471A1 Apoptosis inhibitor |
| 07/30/2009 | WO2009093463A1 Neuronal cell death inhibitor |
| 07/30/2009 | WO2009092892A2 Novel composition for treating the side effects of anticancer treatments |
| 07/30/2009 | WO2009092891A2 Modification of intrinsically disordered sequences for preparing vaccines |
| 07/30/2009 | WO2009092720A1 4-phenyl-piperazin-1-yl-alkyl-benzoimidazol-2-one derivatives and their use as monoamine neurotransmitter re-uptake inhibitors |
| 07/30/2009 | WO2009092713A1 Compounds which potentiate the ampa receptor and uses thereof in medicine |
| 07/30/2009 | WO2009092712A1 Compounds which potentiate the ampa receptor and uses thereof in medicine |
| 07/30/2009 | WO2009092642A1 Sulfonamides as orexin antagonists |
| 07/30/2009 | WO2009092566A1 Substituted amino-benzimidazoles, medicaments comprising said compound, their use and their method of manufacture |
| 07/30/2009 | WO2009092565A1 Substituted tetrahydroimidazopyridine compounds and the use thereof in pharmaceuticals |
| 07/30/2009 | WO2009092324A1 Oxazolidine derivatives as nmda antagonists |
| 07/30/2009 | WO2009092129A1 Delayed release pharmaceutical composition of duloxetine |
| 07/30/2009 | WO2009068042A3 Novel peptides derived from ncam (fgls) |
| 07/30/2009 | WO2009050242A3 Heterocycle-substituted piperazino-dihydrothienopyrimidines |
| 07/30/2009 | WO2009045488A3 Novel crystalline forms of armodafinil and preparation thereof |
| 07/30/2009 | WO2009043464A3 Astressin and beta- endorphin for use as therapeutic agents |
| 07/30/2009 | WO2009043451A3 Use of chorionic gonadotropin-beta (109-145) as a therapeutic agent |
| 07/30/2009 | WO2009043450A3 Use of neurotrophic factor for retinal cholinergic neurons (nfrcn) and chorionic gonadotropin-beta (109-145) as therapeutic agents |
| 07/30/2009 | WO2009043449A3 Use of a peptide as a therapeutic agent |
| 07/30/2009 | WO2009043447A3 Use of a peptide as a therapeutic agent |
| 07/30/2009 | WO2009040004A3 Use of a peptide as a therapeutic agent |
| 07/30/2009 | WO2009033813A3 Use of a peptide as a therapeutic agent |
| 07/30/2009 | WO2009033774A3 Use of a laminin nonapeptide as a therapeutic agent |
| 07/30/2009 | WO2009033769A3 Use of cortistatin 14 and others as a therapeutic agent |
| 07/30/2009 | WO2009033722A8 Use of a octreotide as a therapeutic agent |
| 07/30/2009 | WO2009027349A3 Treatment and prevention of neurodegenerative diseases |
| 07/30/2009 | WO2009024980A3 Pyrimidine and pyridine derivatives as posh and posh-ap inhibitors |
| 07/30/2009 | WO2008157302A3 Methods for treatment and prevention of tauopathies and amyloid beta amyloidosis by modulating crf receptor signaling |